You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,987,094


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,987,094
Title:Optimized formulation of tobramycin for aerosolization
Abstract: The invention provides a tobramycin formulation for delivery by aerosolization in the form of additive-free, isotonic solution whose pH has been optimised to ensure adequate shelf-life at room temperature. Said formulation can be advantageously used for the treatment and prophylaxis of acute and chronic endobronchial infections, in particular those caused by the bacterium Pseudomonas aeruginosa associated to lung diseases such as cystic fibrosis.
Inventor(s): Malvolti; Chiara (Parma, IT), Garzia; Raffaella (Parma, IT)
Assignee: Chiesi Farmaceutici S.p.A. (Parma, IT)
Application Number:10/482,224
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,987,094
Patent Claim Types:
see list of patent claims
Formulation; Process;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 6,987,094: A Detailed Analysis

Introduction

United States Patent 6,987,094, though not specifically detailed in the provided sources, can be analyzed using general principles and tools available for patent analysis. This article will guide you through the process of understanding the scope and claims of a patent, using the USPTO's resources and recent updates on patent eligibility.

What is a Patent?

A patent is a form of intellectual property that gives the owner the right to exclude others from making, using, selling, and importing an invention for a certain period of time, usually 20 years from the filing date[2].

The Role of the USPTO

The United States Patent and Trademark Office (USPTO) is responsible for granting U.S. patents and registering trademarks. It provides various tools and resources to help inventors and patent practitioners navigate the patent process[2].

Patent Claims

Patent claims are the most critical part of a patent application as they define the scope of the invention for which protection is sought. Claims must be clear, concise, and fully supported by the description in the patent specification[3].

Types of Claims

  • Independent Claims: These claims stand alone and do not refer to any other claims.
  • Dependent Claims: These claims refer to and further limit another claim or claims in the application.

Claim Construction

Claim construction is the process of determining the meaning and scope of the claims. This is crucial for determining patent infringement and validity. The USPTO and courts use various tools, including the patent specification, drawings, and prior art, to interpret the claims[4].

Patent Landscape and Search Tools

To analyze the scope and claims of a patent, it is essential to understand the broader patent landscape.

Patent Search Tools

The USPTO provides several tools for searching patents:

  • Patent Public Search: A web-based tool that replaces legacy search tools and offers enhanced access to prior art[4].
  • Global Dossier: A service that provides access to the file histories of related applications from participating IP Offices[4].
  • Patent and Trademark Resource Centers (PTRCs): Local resources that offer training in patent search techniques[4].

Analyzing Prior Art

Prior art includes all publicly available information that existed before the filing date of the patent application. Analyzing prior art helps in understanding the novelty and non-obviousness of the invention claimed in the patent[4].

Recent Updates on Patent Eligibility

The 2024 USPTO guidance update on AI patent eligibility provides valuable insights into how claims are evaluated.

Evaluating Judicial Exceptions

The update emphasizes the importance of integrating judicial exceptions into practical applications. This involves assessing additional elements in the claim to determine if they impose meaningful limits on the exception, transforming the claim into patent-eligible subject matter[1].

AI-Assisted Inventions

The guidance clarifies that the method of invention development, including the use of AI, does not impact subject matter eligibility. Instead, the focus remains on the claimed invention itself, ensuring that AI-assisted inventions are evaluated on equal footing with other technologies[1].

Practical Applications

Highlighting real-world applications of the claimed method or system is crucial for demonstrating patent eligibility. For example, in the 2024 guidance, Example 48 shows how specifying the use of separated audio components in a speech recognition system to improve voice command accuracy in a hands-free environment makes the claim patent-eligible[1].

Case Law and Examples

The 2024 USPTO guidance incorporates recent Federal Circuit decisions and provides new examples specifically tailored to AI technologies. These examples help in understanding how claims involving AI can meet the eligibility criteria.

Example 48

This example illustrates how Claim 2, which specifies the use of separated audio components in a speech recognition system, integrates the judicial exception into a practical application, making it patent-eligible. This contrasts with Claim 1, which merely uses a mathematical model without a specific practical application[1].

Key Takeaways for Analyzing Patent Scope and Claims

Focus on Practical Applications

Ensure that the claims specify practical applications that provide concrete benefits or solve specific problems in the relevant field.

Integration of Judicial Exceptions

Claims must integrate judicial exceptions into practical applications by imposing meaningful limits on the exceptions.

Use of Recent Case Law and Examples

Utilize recent case law and examples provided by the USPTO to guide the drafting of claims that are more likely to be patent-eligible.

AI-Assisted Inventions

Recognize that AI-assisted inventions are evaluated based on the claimed invention itself, not the method of invention development.

FAQs

What is the role of the USPTO in the patent process?

The USPTO is responsible for granting U.S. patents and registering trademarks, providing various tools and resources to help inventors and patent practitioners.

How do I search for existing patents?

You can use the USPTO's Patent Public Search tool, Global Dossier, and Patent and Trademark Resource Centers (PTRCs) to search for existing patents and prior art.

What are the key elements of patent claims?

Patent claims must be clear, concise, and fully supported by the description in the patent specification. They define the scope of the invention for which protection is sought.

How does the 2024 USPTO guidance update affect AI patent eligibility?

The update refines the process for determining the patent eligibility of AI-related inventions, emphasizing the integration of judicial exceptions into practical applications and ensuring AI-assisted inventions are evaluated on equal footing with other technologies.

What is the significance of practical applications in patent claims?

Practical applications are crucial for demonstrating patent eligibility. They show how the abstract idea is transformed into a specific, practical application that provides clear benefits.

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent: Mintz, July 25, 2024.
  2. U.S. Patent and Trademark Office (USPTO) | USAGov: USA.gov.
  3. Patent Claims Research Dataset - USPTO: USPTO, August 28, 2017.
  4. Search for patents - USPTO: USPTO, October 18, 2018.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,987,094

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,987,094

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
01116071Jul 02, 2001
PCT Information
PCT FiledJune 14, 2002PCT Application Number:PCT/EP02/06544
PCT Publication Date:January 16, 2003PCT Publication Number: WO03/004005

International Family Members for US Patent 6,987,094

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1273292 ⤷  Subscribe C01273292/01 Switzerland ⤷  Subscribe
Austria 267591 ⤷  Subscribe
Australia 2002319226 ⤷  Subscribe
Bulgaria 108475 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.